David J Serisier

Summary

Affiliation: South Brisbane
Country: Australia

Publications

  1. ncbi request reprint Clinical application of direct sputum sensitivity testing in a severe infective exacerbation of cystic fibrosis
    David J Serisier
    Adult Cystic Fibrosis Unit, Southampton University Hospital NHS Trust, Southampton, Hampshire, UK
    Pediatr Pulmonol 35:463-6. 2003
  2. doi request reprint Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases
    David J Serisier
    Department of Respiratory Medicine, Mater Adult Hospital, South Brisbane, QLD, Australia University of Queensland and Mater Medical Research Institute, Mater Health Services, South Brisbane, QLD, Australia Electronic address
    Lancet Respir Med 1:262-74. 2013
  3. doi request reprint Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
    David J Serisier
    Department of Respiratory Medicine, Mater Medical Research Institute and University of Queensland, Mater Adult Hospital, South Brisbane, Queensland, Australia
    Thorax 68:812-7. 2013
  4. doi request reprint Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial
    David J Serisier
    Department of Respiratory Medicine, Level 9, Mater Adult Hospital, Raymond Terr, South Brisbane, Queensland 4101, Australia
    JAMA 309:1260-7. 2013
  5. doi request reprint Australasian respiratory and emergency physicians do not use the pneumonia severity index in community-acquired pneumonia
    David J Serisier
    Department of Respiratory Medicine, Mater Adult Hospital, Auchenflower, Queensland, Australia
    Respirology 18:291-6. 2013
  6. doi request reprint Antimicrobial susceptibility and synergy studies of cystic fibrosis sputum by direct sputum sensitivity testing
    D J Serisier
    Department of Respiratory Medicine and University of Qld, Mater Adult Hospital Infection, Inflammation and Immunity Program, Mater Medical Research Institute, Lvl 9, Raymond Tce, South Brisbane, QLD, Australia
    Eur J Clin Microbiol Infect Dis 31:3211-6. 2012
  7. doi request reprint Inhaled antibiotics for lower respiratory tract infections: focus on ciprofloxacin
    D J Serisier
    Dept of Respiratory Medicine, University of Queensland, South Brisbane, Queensland, Australia
    Drugs Today (Barc) 48:339-51. 2012
  8. doi request reprint Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations
    D J Serisier
    Dept of Respiratory Medicine, Lvl 9, Mater Adult Hospital, Raymond Tce, South Brisbane, QLD 4101, Australia
    Respir Med 105:946-9. 2011
  9. pmc Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum
    David J Serisier
    Department of Respiratory Medicine, Mater Adult Hospital, Brisbane, Australia
    Respir Res 10:63. 2009
  10. ncbi request reprint Effect of albuterol on maximal exercise capacity in cystic fibrosis
    David J Serisier
    DM, Department of Respiratory Medicine, Mater Adult Hospital, South Brisbane, QLD 4101, Australia
    Chest 131:1181-7. 2007

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Clinical application of direct sputum sensitivity testing in a severe infective exacerbation of cystic fibrosis
    David J Serisier
    Adult Cystic Fibrosis Unit, Southampton University Hospital NHS Trust, Southampton, Hampshire, UK
    Pediatr Pulmonol 35:463-6. 2003
    ..DSST is a form of "whole" sputum sensitivity testing that provides information on antibiotic synergy, and may more accurately reflect in vivo antibiotic sensitivity patterns in cystic fibrosis...
  2. doi request reprint Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases
    David J Serisier
    Department of Respiratory Medicine, Mater Adult Hospital, South Brisbane, QLD, Australia University of Queensland and Mater Medical Research Institute, Mater Health Services, South Brisbane, QLD, Australia Electronic address
    Lancet Respir Med 1:262-74. 2013
    ....
  3. doi request reprint Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
    David J Serisier
    Department of Respiratory Medicine, Mater Medical Research Institute and University of Queensland, Mater Adult Hospital, South Brisbane, Queensland, Australia
    Thorax 68:812-7. 2013
    ..Dual release ciprofloxacin for inhalation (DRCFI) contains liposomal ciprofloxacin, formulated to optimise airway antibiotic delivery...
  4. doi request reprint Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial
    David J Serisier
    Department of Respiratory Medicine, Level 9, Mater Adult Hospital, Raymond Terr, South Brisbane, Queensland 4101, Australia
    JAMA 309:1260-7. 2013
    ..Macrolide antibiotics such as erythromycin may improve clinical outcomes in non-cystic fibrosis (CF) bronchiectasis, although associated risks of macrolide resistance are poorly defined...
  5. doi request reprint Australasian respiratory and emergency physicians do not use the pneumonia severity index in community-acquired pneumonia
    David J Serisier
    Department of Respiratory Medicine, Mater Adult Hospital, Auchenflower, Queensland, Australia
    Respirology 18:291-6. 2013
    ..Until recently, the Australasian Therapeutic Guidelines has recommended the use of the Pneumonia Severity Index (PSI) in spite of poor user-friendliness...
  6. doi request reprint Antimicrobial susceptibility and synergy studies of cystic fibrosis sputum by direct sputum sensitivity testing
    D J Serisier
    Department of Respiratory Medicine and University of Qld, Mater Adult Hospital Infection, Inflammation and Immunity Program, Mater Medical Research Institute, Lvl 9, Raymond Tce, South Brisbane, QLD, Australia
    Eur J Clin Microbiol Infect Dis 31:3211-6. 2012
    ..Future studies will determine whether these potential theoretical advantages translate into clinical benefits...
  7. doi request reprint Inhaled antibiotics for lower respiratory tract infections: focus on ciprofloxacin
    D J Serisier
    Dept of Respiratory Medicine, University of Queensland, South Brisbane, Queensland, Australia
    Drugs Today (Barc) 48:339-51. 2012
    ....
  8. doi request reprint Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations
    D J Serisier
    Dept of Respiratory Medicine, Lvl 9, Mater Adult Hospital, Raymond Tce, South Brisbane, QLD 4101, Australia
    Respir Med 105:946-9. 2011
    ..Widespread, injudicious use of long-acting macrolides, particularly azithromycin, risks significantly increasing population antimicrobial resistance...
  9. pmc Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum
    David J Serisier
    Department of Respiratory Medicine, Mater Adult Hospital, Brisbane, Australia
    Respir Res 10:63. 2009
    ..We therefore reassessed this question using whole sputum macrorheology. Additionally, we wished to further explore the relationships between sputum rheology, inflammation and infection...
  10. ncbi request reprint Effect of albuterol on maximal exercise capacity in cystic fibrosis
    David J Serisier
    DM, Department of Respiratory Medicine, Mater Adult Hospital, South Brisbane, QLD 4101, Australia
    Chest 131:1181-7. 2007
    ..We tested the hypothesis that inhaled albuterol would improve maximal exercise performance in CF subjects with airflow obstruction, as a result of acute bronchodilation...
  11. ncbi request reprint Effect of a simple educational intervention on the hospital management of community-acquired pneumonia
    David J Serisier
    Department of Respiratory Medicine, Mater Adult Hospital, Brisbane, Queensland, Australia
    Respirology 12:389-93. 2007
    ..While quality improvement projects have been linked to better CAP management and outcomes, there are limited data evaluating simple and achievable interventions...
  12. pmc Bacterial activity in cystic fibrosis lung infections
    Geraint B Rogers
    Department of Life Sciences, King s College London, London, UK
    Respir Res 6:49. 2005
    ..The aim of this study was to determine whether the species present were active and, as such, worthy of further investigation as potential pathogens...
  13. ncbi request reprint Eradication of pulmonary methicillin-resistant staphylococcus aureus (MRSA) in cystic fibrosis with linezolid
    David J Serisier
    J Cyst Fibros 3:61. 2004